Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease

25 Jul 2011

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Insect symbiosis and bacterial influences
Share to Mosquito-borne diseases and control
Share to Viral Infections and Vectors

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 21777637
DOI: 10.1016/j.vaccine.2011.07.021

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced diseasePMID 21777637Read ↗

Approaches of dengue control: vaccine strategies and future aspectsSemantic proximity Read ↗

Construction, characterization and immunogenicity of recombinant yellow fever 17D-dengue type 2 virusesSemantic proximity Read ↗

Elaboration of tetravalent antibody responses against dengue viruses using a subunit vaccine comprised of a single consensus dengue envelope sequenceSemantic proximity Read ↗

A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infectionSemantic proximity Read ↗

Subunit vaccine formulations based on recombinant envelope proteins of Chikungunya virus elicit balanced Th1/Th2 response and virus-neutralizing antibodies in miceSemantic proximity Read ↗

Vectored vaccines to protect against PRRSVSemantic proximity Read ↗

Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: Their immunity and protective efficacy in miceSemantic proximity Read ↗

Vaccines to prevent severe acute respiratory syndrome coronavirus-induced diseaseSemantic proximity Read ↗

Advancements in the development of subunit influenza vaccinesSemantic proximity Read ↗

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis virusesSemantic proximity Read ↗

A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primatesSemantic proximity Read ↗

From the World Health Organization. Development of dengue and Japanese encephalitis vaccines.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.